This inventor holds 1 USPTO granted patent. Top assignees: Kanagawa Prefectural Hospital Organization, The University of Tokyo. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024
Title: Mitsuyo Yoshihara: Innovator in Mesothelioma Detection and Treatment
Introduction
Mitsuyo Yoshihara is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of mesothelioma. Her innovative work has the potential to improve patient outcomes and advance the understanding of this challenging disease.
Latest Patents
Mitsuyo Yoshihara holds a patent for an "Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma." This invention provides an antibody specifically designed for detecting mesothelioma, characterized by high specificity and sensitivity. The patent also outlines a method for diagnosing mesothelioma using this antibody, along with a reagent and a kit for diagnostic purposes. Furthermore, it includes a pharmaceutical composition containing the antibody or its antigen-binding fragment for treating mesothelioma.
Career Highlights
Throughout her career, Mitsuyo Yoshihara has worked with esteemed organizations such as the Kanagawa Prefectural Hospital Organization and The University of Tokyo. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mitsuyo has collaborated with notable colleagues, including Shoutaro Tsuji and Taihei Kageyama. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in medical diagnostics.
Conclusion
Mitsuyo Yoshihara's contributions to the field of mesothelioma detection and treatment exemplify her dedication to advancing medical science. Her innovative patent and collaborative efforts highlight her role as a key figure in the fight against this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile